TY - JOUR
T1 - Total mesopancreas excision for periampullary malignancy: a single-center propensity score-matched comparison of long-term outcomes
AU - Quero, Giuseppe
AU - Fiorillo, Claudio
AU - Menghi, Roberta
AU - Cina, Caterina
AU - Galiandro, Federica
AU - Longo, Fabio
AU - Sofo, Francesco
AU - Rosa, Fausto
AU - Tortorelli, Antonio Pio
AU - Giustiniani, Maria Cristina
AU - Inzani, Frediano
AU - Alfieri, Sergio
PY - 2020
Y1 - 2020
N2 - Purpose: Few comparative studies are available on the long-term prognostic role of mesopancreas (MP) excision after pancreaticoduodenectomy (PD). We compared the long-term outcomes of patients undergoing standard PD (sPD) and PD with MP excision (PD-MPe).
Methods: Sixty sPDs were compared to 60 matched PD-MPe patients for intraoperative and postoperative data, histopathological findings, and long-term outcomes.
Results: R0 rate was similar in the two groups (p = 0.17). However, PD-MPe related to a lower rate of MP resection margin positivity (16.7% vs 5%; p = 0.04) and to a higher harvested lymph nodes number (19.8 ± 7.6 vs 10.1 ± 5.1; p < 0.0001). Local tumor recurrence was more frequent in the sPD cohort (55.5% vs 26.8% in the PD-MPe group; p = 0.002), with a consequent worse disease-free survival (DFS) (14.8% vs 22.3%; p = 0.04). An inferior 5-year overall survival (OS) was noted in case of MP margin positivity compared with MP margin negativity (0% vs 29%; p < 0.0001). MP positivity resulted as an independent prognostic factor for both a worse OS and DFS at the multivariate analysis.
Conclusion: PD-MPe offers clinical advantages in terms of MP resection margin status, local recurrence, long-term mortality, and DFS. The lower MP positivity rate, achieved with PD-MPe, leads to better outcomes both in terms of OS and DFS.
AB - Purpose: Few comparative studies are available on the long-term prognostic role of mesopancreas (MP) excision after pancreaticoduodenectomy (PD). We compared the long-term outcomes of patients undergoing standard PD (sPD) and PD with MP excision (PD-MPe).
Methods: Sixty sPDs were compared to 60 matched PD-MPe patients for intraoperative and postoperative data, histopathological findings, and long-term outcomes.
Results: R0 rate was similar in the two groups (p = 0.17). However, PD-MPe related to a lower rate of MP resection margin positivity (16.7% vs 5%; p = 0.04) and to a higher harvested lymph nodes number (19.8 ± 7.6 vs 10.1 ± 5.1; p < 0.0001). Local tumor recurrence was more frequent in the sPD cohort (55.5% vs 26.8% in the PD-MPe group; p = 0.002), with a consequent worse disease-free survival (DFS) (14.8% vs 22.3%; p = 0.04). An inferior 5-year overall survival (OS) was noted in case of MP margin positivity compared with MP margin negativity (0% vs 29%; p < 0.0001). MP positivity resulted as an independent prognostic factor for both a worse OS and DFS at the multivariate analysis.
Conclusion: PD-MPe offers clinical advantages in terms of MP resection margin status, local recurrence, long-term mortality, and DFS. The lower MP positivity rate, achieved with PD-MPe, leads to better outcomes both in terms of OS and DFS.
KW - Long-term outcomes
KW - Mesopancreas
KW - Pancreaticoduodenectomy
KW - Periampullary malignancy
KW - Long-term outcomes
KW - Mesopancreas
KW - Pancreaticoduodenectomy
KW - Periampullary malignancy
UR - http://hdl.handle.net/10807/174678
U2 - 10.1007/s00423-020-01873-4
DO - 10.1007/s00423-020-01873-4
M3 - Article
SN - 1435-2443
VL - 405
SP - 303
EP - 312
JO - Langenbeck's Archives of Surgery
JF - Langenbeck's Archives of Surgery
ER -